Jim Simons’s Procept Biorobotics PRCT Stock Holding History

Jim Simons’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.91M	Sell	116,166 -1,300	-1%	-$36.6K	﹤0.01%	1680
2025 Q4	$3.7M	Buy	+117,466	New	+$3.9M	0.01%	1502
2025 Q2	–	Sell	-314,466	Closed	-$18.3M	–	3818
2025 Q1	$18.3M	Buy	314,466 +36,000	+13%	+$2.46M	0.03%	700
2024 Q4	$22.4M	Buy	+278,466	New	+$23.8M	0.03%	614
2024 Q3	–	Sell	-45,966	Closed	-$2.81M	–	3806
2024 Q2	$2.81M	Buy	+45,966	New	+$2.73M	﹤0.01%	1660
2023 Q2	–	Sell	-63,566	Closed	-$1.8M	–	4196
2023 Q1	$1.8M	Buy	+63,566	New	+$2.24M	﹤0.01%	2090
2022 Q1	–	Sell	-179,300	Closed	-$4.48M	–	4375
2021 Q4	$4.48M	Buy	+179,300	New	+$6.63M	0.01%	1602

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jim Simons's PRCT Position: Q1 2026 in Review

Jim Simons reduced its Procept Biorobotics (PRCT) stake by 1.1% in Q1 2026, selling an estimated $36.6K and leaving 116,166 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1680.

Jim Simons first reported a position in PRCT in Q4 2021 and has held it in 7 quarters since. The position peaked at $22.4M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

Jim Simons held 116,166 shares of Procept Biorobotics worth $2.91M as of Q1 2026.
Jim Simons sold 1,300 Procept Biorobotics shares in Q1 2026, an estimated $36.6K.
Procept Biorobotics made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1680 holding.
Jim Simons first reported a position in Procept Biorobotics in Q4 2021 and has held it in 7 quarters since.
Jim Simons's Procept Biorobotics position peaked at $22.4M in Q4 2024.
256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.